tiprankstipranks
Trending News
More News >

Cambium Bio Limited Announces Quotation of New Securities on ASX

Story Highlights
Cambium Bio Limited Announces Quotation of New Securities on ASX

Confident Investing Starts Here:

The latest update is out from Regeneus Ltd. ( (AU:CMB) ).

Cambium Bio Limited has announced the application for quotation of 4,139,650 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, and it signifies a strategic step in enhancing the company’s market presence and liquidity, potentially impacting its stakeholders by increasing the availability of its shares for trading.

More about Regeneus Ltd.

YTD Price Performance: -12.50%

Average Trading Volume: 24,654

Technical Sentiment Consensus Rating: Buy

Current Market Cap: A$4.95M

Find detailed analytics on CMB stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App